




Searching News Database: Lipitor
HSMN NewsFeed - 15 Sep 2020
Mylan and Pfizer Receive European Commission Approval for Proposed Combination of Mylan and Upjohn
Mylan and Pfizer Receive European Commission Approval for Proposed Combination of Mylan and Upjohn
HSMN NewsFeed - 7 Apr 2014
Deciphera Pharmaceuticals Appoints Michael D. Taylor, Ph.D., as President and Chief Executive Officer
Deciphera Pharmaceuticals Appoints Michael D. Taylor, Ph.D., as President and Chief Executive Officer
HSMN NewsFeed - 8 Jan 2014
Mylan Appoints Adele Gulfo as EVP, Global Collaboration and Strategic Operations
Mylan Appoints Adele Gulfo as EVP, Global Collaboration and Strategic Operations
HSMN NewsFeed - 5 Dec 2010
Pfizer Board of Directors Names Ian C. Read President and Chief Executive Officer
Pfizer Board of Directors Names Ian C. Read President and Chief Executive Officer
HSMN NewsFeed - 11 Feb 2010
Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets
Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets
HSMN NewsFeed - 23 Dec 2009
Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement
Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement
HSMN NewsFeed - 12 Sep 2008
CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group
CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group
HSMN NewsFeed - 3 Sep 2008
Cumberland Pharmaceuticals Taps Industry Veteran for Key Executive Position
Cumberland Pharmaceuticals Taps Industry Veteran for Key Executive Position
HSMN NewsFeed - 5 Aug 2008
Marinus Pharmaceuticals Appoints John Krayacich as President and Chief Executive Officer
Marinus Pharmaceuticals Appoints John Krayacich as President and Chief Executive Officer
HSMN NewsFeed - 8 Jul 2008
Pipex Pharmaceuticals Appoints Co-Founder and Vice Chairman Nicholas Stergis as Chief Executive Officer
Pipex Pharmaceuticals Appoints Co-Founder and Vice Chairman Nicholas Stergis as Chief Executive Officer
HSMN NewsFeed - 5 May 2008
Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca
Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca
HSMN NewsFeed - 30 Apr 2008
U.S. Patent and Trademark Office to Confirm Patentability of Lipitor Basic Patent
U.S. Patent and Trademark Office to Confirm Patentability of Lipitor Basic Patent
HSMN NewsFeed - 21 Apr 2008
High-Dose Lipitor Reduced the Risk of Heart Attack and Stroke in Patients with Chronic Kidney Disease
High-Dose Lipitor Reduced the Risk of Heart Attack and Stroke in Patients with Chronic Kidney Disease
HSMN NewsFeed - 25 Feb 2008
Pfizer Voluntarily Withdraws Lipitor Advertising Featuring Dr. Robert Jarvik
Pfizer Voluntarily Withdraws Lipitor Advertising Featuring Dr. Robert Jarvik
HSMN NewsFeed - 23 Jan 2008
Robert A. Scott, M.D., Appointed Chief Medical Officer of Cerenis Therapeutics
Robert A. Scott, M.D., Appointed Chief Medical Officer of Cerenis Therapeutics
HSMN NewsFeed - 15 Jan 2008
First Head to Head Study Comparing Crestor(TM) and Lipitor(R) Effects on the Treatment of Atherosclerosis
First Head to Head Study Comparing Crestor(TM) and Lipitor(R) Effects on the Treatment of Atherosclerosis
HSMN NewsFeed - 14 Jan 2008
Pfizer Receives Initial Communication from U.S. Patent and Trademark Office Regarding Lipitor Basic Patent
Pfizer Receives Initial Communication from U.S. Patent and Trademark Office Regarding Lipitor Basic Patent
HSMN NewsFeed - 4 Sep 2007
Ensemble Discovery Names Michael D. Taylor, PhD as President and Chief Executive Officer
Ensemble Discovery Names Michael D. Taylor, PhD as President and Chief Executive Officer
HSMN NewsFeed - 12 Jul 2007
Resverlogix Corp.: Dr. Roger Newton, Co-Discoverer of Lipitor(R), Commences his Board of Directors Position
Resverlogix Corp.: Dr. Roger Newton, Co-Discoverer of Lipitor(R), Commences his Board of Directors Position
HSMN NewsFeed - 28 Mar 2007
Daiichi Sankyo, Inc. Announces Filing For WelChol Label Change to Include Ezetimibe Efficacy Data
Daiichi Sankyo, Inc. Announces Filing For WelChol Label Change to Include Ezetimibe Efficacy Data
HSMN NewsFeed - 27 Mar 2007
Lipitor Significantly Lowered Hospitalization Costs for Patients with Heart Disease, Two New Analyses Show
Lipitor Significantly Lowered Hospitalization Costs for Patients with Heart Disease, Two New Analyses Show
HSMN NewsFeed - 26 Mar 2007
Two New Imaging Studies Show Higher Dose Lipitor Stopped the Progression of Atherosclerosis
Two New Imaging Studies Show Higher Dose Lipitor Stopped the Progression of Atherosclerosis
HSMN NewsFeed - 7 Mar 2007
Lipitor Receives FDA Approval for Five New Indications in Patients With Heart Disease
Lipitor Receives FDA Approval for Five New Indications in Patients With Heart Disease
HSMN NewsFeed - 23 Feb 2007
Danish Court Issues Preliminary Injunction That Prohibits Sale of Generic Lipitor Product
Danish Court Issues Preliminary Injunction That Prohibits Sale of Generic Lipitor Product
HSMN NewsFeed - 26 Jan 2007
Astellas and Pfizer Reached Settlement on Declaratory Judgment Action Relating to Lipitor Agreement
Astellas and Pfizer Reached Settlement on Declaratory Judgment Action Relating to Lipitor Agreement
HSMN NewsFeed - 20 Dec 2006
Australian Federal Court Grants Favorable Decision to Ranbaxy on Pfizer's Atorvastatin Patent
Australian Federal Court Grants Favorable Decision to Ranbaxy on Pfizer's Atorvastatin Patent
HSMN NewsFeed - 4 Dec 2006
Risk of Heart Attack Significantly Reduced in About 90 days by Modern Combination of Drugs
Risk of Heart Attack Significantly Reduced in About 90 days by Modern Combination of Drugs
HSMN NewsFeed - 13 Nov 2006
WelChol and Ezetimibe Combination Therapy Provides Significant LDL-C Reductions
WelChol and Ezetimibe Combination Therapy Provides Significant LDL-C Reductions
HSMN NewsFeed - 23 Oct 2006
U.S. Appeals Court Denies Ranbaxy Petition for Rehearing Regarding Main Patent in Lipitor Case
U.S. Appeals Court Denies Ranbaxy Petition for Rehearing Regarding Main Patent in Lipitor Case
HSMN NewsFeed - 17 Oct 2006
Austrian Patent Office Rules in Pfizer's Favor, Ranbaxy Product Would Infringe Basic Lipitor Patent
Austrian Patent Office Rules in Pfizer's Favor, Ranbaxy Product Would Infringe Basic Lipitor Patent
HSMN NewsFeed - 9 Aug 2006
Pfizer's Lipitor Shown to Reduce the Chance of Additional Strokes in Stroke Patients
Pfizer's Lipitor Shown to Reduce the Chance of Additional Strokes in Stroke Patients
HSMN NewsFeed - 28 Jul 2006
Pfizer Board of Directors Names Jeffrey B. Kindler Chief Executive Officer
Pfizer Board of Directors Names Jeffrey B. Kindler Chief Executive Officer
HSMN NewsFeed - 25 Apr 2006
Pfizer Says Austrian Court Ruling on Lipitor Enantiomer Patent Has No Effect on Cases in Other Jurisdictions
Pfizer Says Austrian Court Ruling on Lipitor Enantiomer Patent Has No Effect on Cases in Other Jurisdictions
HSMN NewsFeed - 14 Mar 2006
New Torcetrapib/Atorvastatin Research Further Supports Raising 'Good' HDL Cholesterol
New Torcetrapib/Atorvastatin Research Further Supports Raising 'Good' HDL Cholesterol
HSMN NewsFeed - 23 Feb 2006
Kos Reports Summary Results of Key Phase IV Research and Development Studies
Kos Reports Summary Results of Key Phase IV Research and Development Studies
HSMN NewsFeed - 21 Feb 2006
Vasogen Announces Plans for Terrance H. Gregg to Succeed William R. Grant as Chairman
Vasogen Announces Plans for Terrance H. Gregg to Succeed William R. Grant as Chairman
Additional items found! 62

Members Archive contains
62 additional stories matching:
Lipitor
(Password required)
Lipitor
(Password required)